Prostatic duct carcinoma with combined prostatic duct adenocarcinoma and urothelial carcinoma features: Report of a case

International Journal of Surgical Pathology

Volumn 12, Issue 3, 2004, Pages 293-297

  Pacchioni, D ^a   Casetta, G ^a   Piovano, M ^a   Fraire, F ^a   Volante, M ^a   Sapino, A ^a   Tizzani, A ^a   Bussolati, G ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Dept of Biomed Sci and Oncology ^*  (Italy)

Author keywords

Ki 67 proliferation index; p53; Prostate; Prostatic duct adenocarcinoma; Urothelial carcinoma

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

AGED; ARTICLE; CASE REPORT; CYSTOSCOPY; ECHOGRAPHY; GERIATRIC PATIENT; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; TRANSURETHRAL RESECTION; TUMOR LOCALIZATION; UROGENITAL TRACT TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, DUCTAL; CARCINOMA, TRANSITIONAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 4043146401     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690401200314     Document Type: Article

References (28)

1. Melicow MM, Pachter MR. Endometrial carcinoma of the prostatic utricle (uterus masculinus). Cancer 20:1715-1721, 1967
2. Tannenbaum M. Endometrial tumors and/or associated carcinomas of the prostate. Urology 6:372-375, 1975
3. Bostwick DG, Kindrauchuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Clinical, pathological and ultrastructural features. Am J Surg Pathol 9:595-609, 1985
4. Varo Solis C, Soto Delgado M, Hens Perez A, Estudillo Gonzales F, Sanchez Bernal C, Gonzales Moreno D, Vasquez MR. Transitional carcinoma of the prostate. Actas Urol Esp 23:806-810, 1999
5. Chevile JC, Dundore PA, Bostwick DG, Lieber MM, Batts KP, Sebo TJ, Farrow GM. Transitional cell carcinoma of the prostate: Clinicopathologic study of 50 cases. Cancer 82:703-707, 1998
6. Gown AM, Wever N, Battifora H. Microwave-based antigenic unmasking. A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1:256-266, 1993
7. Rosai J. Ackerman's surgical pathology, 8th ed. The Mosby Year Book, St Louis, 1996
8. Bates HR Jr, Thornton JL. Adenocarcinoma of primary prostatic ducts and utricle. Arch Pathol Lab Med 96:207, 1973
9. Vandersteen DP, Wiermerslage SJ, Cohen MB. Prostatic duct adenocarcinoma: A cytologic and histologic case report with review of the literature. Diagn Cytopathol 17:480-483, 1997
10. Drake WM, Burrows S. Papillary carcinoma of prostatic ducts. Urology 3:621-623, 1974
11. Randolph TL, Amin M, Ro JY, Ayala AG. Histologic variants of adenocarcinoma and other carcinomas of the prostate: Pathologic criteria and clinical significance. Modern Pathol 10:612-629, 1997
12. Zaloudek C, Williams JW, Kempson RL. "Endometrial" adenocarcinoma of the prostate: A distinctive tumor of prostatic duct origin. Cancer 37:2255-2262, 1976
13. Christensen WN, Steinberg C, Walsh PC, Epstein JI. Prostatic duct adenocarcinoma: Findings at radical prostatectomy. Cancer 67:2118-2124, 1991
14. Millar EK, Sharma NK, Lessels AM. Ductal (endometrioid) adenocarcinoma of the prostate: A clinicopathological study of 16 cases. Histopathology 29:11-19, 1996
15. Carney JA, Kelalis PP. Endometrial carcinoma of the prostatic utricle. Am J Clin Pathol 60:565-569, 1973
16. Melicow MM, Tannenbaum M. Endometrial carcinoma of uterus masculinus (prostatic utricle). Report of six cases. J Urol 106:892-902, 1971
17. Young BW, Lagios MD. Endometrial (papillary) carcinoma of prostatic utricle-response to orchiectomy. Cancer 32:1293-1300, 1973
18. Lee SG. Endometrioid adenocarcinoma of the prostate. A clinicopathologic and immunohistochemical study. J Surg Oncol 55:235-238, 1994
19. Ro JY, Ayala AG, Wishnow KI, Ordonez NG. Prostatic duct adenocarcinoma with endometrioid features: Immunohistochemical and electron microscopic study. Semin Diagn Pathol 5:301-311, 1988
20. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer 57:111-119, 1986
21. Stavropoulous EI, Velogianni KS, Stefanou GK, Pavlidis N. Endometrioid carcinoma of the prostate. The diagnostic value of Leu 7 and prostatic specific antigen. Br J Urol 71:309-312, 1993
22. Saramatunga H, Singh M. Distribution pattern of basal cells detected by Cytokeratin 34βE12 in primary prostatic duct adenocarcinoma. Am J Surg Pathol 21:435-440, 1997
23. Vale JA, Patel A, Ball AJ, Hendry WF, Chappel ME, Fisher C. Endometrioid carcinoma of the prostate. A misnomer? J R Soc Med 85:394-396, 1992
24. Amin MB, Ro JY, Ayala AG. Clinical relevance of histologic variants of prostate cancer. Cancer Bull 45:403-410, 1993
25. Cheng L, Pisansky TM, Sebo TJ, Leibovich BC, Ramnani DM, Weaver AL, Scherer BG, Blute ML, Zincke H, Bostwick DG. Cell proliferation in prostate cancer patients with lymph node metastasis: A marker for progression. Clin Cancer Res 5:2820-2823, 1999
26. Matsuura H, Hayashi N, Kawamura J, Shiraishi T, Yatani R. Prognostic significance of Ki67 expression in advanced prostate cancers in relation to disease progression after androgen ablation. Eur Urol 37:212-217, 2000
27. Cheng L, Sebo TJ, Cheville JC, Pisansky TM, Slezak J, Bergstralh EJ, Pacelli A, Neumann M, Zincke H, Bostwick DG. P53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer 85:1293-1299, 1999
28. Abe KO, Ohishi Y, Onodera S, Kiyota H, Asano K, Hinyokika Kiyo. A case of primary transitional cell carcinoma of the prostate responsive to combination chemotherapy with methotrexate, epirubicin and cisplatin. Hinyokika Kiyo 44:415-417, 1998